Altered ubiquitin/proteasome expression in anastomotic intimal hyperplasia

Journal of Vascular Surgery

Volumn 34, Issue 6, 2001, Pages 1016-1022

  Stone, David H ^a   Sivamurthy, Nayan ^a   Contreras, Mauricio A ^a   Fitzgerald, Lisa ^a   LoGerfo, Frank W ^a   Quist, William C ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; POLITEF; PROTEASOME; SCLEROPROTEIN; UBIQUITIN;

ANASTOMOSIS; ANIMAL; ARTICLE; BLOOD VESSEL TRANSPLANTATION; CAROTID ARTERY; CELL CYCLE; DISEASE MODEL; DNA MICROARRAY; DOG; DOWN REGULATION; EQUIPMENT; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; INSTRUMENTATION; INTIMA; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PROSTHESIS FAILURE; STANDARD; TIME;

ANASTOMOSIS, SURGICAL; ANIMAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CAROTID ARTERIES; CELL CYCLE; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; DOGS; DOWN-REGULATION; EQUIPMENT FAILURE ANALYSIS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HYPERPLASIA; MULTIENZYME COMPLEXES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYTETRAFLUOROETHYLENE; PROSTHESIS FAILURE; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TUNICA INTIMA; UBIQUITIN;

EID: 0035656723     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.119888     Document Type: Article

References (23)

1. LoGerfo FW, Grawshaw HM, Quist WC, Nowak MD, Haudenschild CC. Downstream anastomotic hyperplasia: a mechanism of failure in Dacron arterial grafts. Ann Surg 1983;1197:479-83.
2. Imparato AM, Bracco A, Kim GF, Zeff R. Intimal and neointimal fibrous proliferation causing failure of arterial reconstruction. Surgery 1972;72:1007-17.
3. Clowes AW, Reidy MA. Mechanisms of arterial graft failure: the role of cellular proliferation. Ann NY Acad Sci 1987;516:673-8.
4. Sottiurai V, Yow J, Batson R, Sue SL, Jones R, Nakamura YA. Distal intimai hyperplasia: histopathologic character and biogenesis. Ann Vasc Surg 1989;3:26-33.
5. Mills JL, Fujitani RM, Taylor SM. The characteristics and anatomic distribution of lesions that cause reverse vein graft failure: a five-year prospective study. J Vasc Surg 1993;17:195-206.
6. Hamden AD, Aiello LP, Quist WC, Ozaki CK, Contreras MA, Phaneuf MD, et al. Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential display. J Vasc Surg 1995;21:228-34.
7. Rzucidlo EM, Quist WC, Hamdan AH, LoGerfo FW. Interferon gamma up-regulates a novel protein in vascular smooth muscle cells. J Vasc Surg 1999;29:317-25.
8. Johnston SC, Larsen CN, Cook WJ, Wilkinson KD, Hill CP. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 angstrom resolution. EMBO J 1997;16:3787-796.
9. National Institutes for Health. Guide for the care and use of laboratory animals (revised). Bethesda (MD): the Institutes; 1985. NIH publication No. 86-23.
10. Cordero JA, Quist WC, Hamden AD, Phaneuf MD, Contreras MA, LoGerfo FW. Identification of multiple genes with altered expression at the distal anastomosis of healing polytetrafuoroethylene grafts. J Vasc Surg 1998;28:157-66.
11. Adler K, Broadbent J, Garlick R, Joseph R, Khimani A, Mikulskis A, et al. Micromax: a highly sensitive system for differential gene expression on microarrays. Microarray Biochip Technol 2000;221-30.
12. DeMartino GN, Slaughter CA. Regulatory proteins of the proteasome. Enzyme Protein 1993;47:314-24.
13. Ferrel K, Wilkinson CR, Dubiel W, Gordon C. Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci 2000;25:83-8.
14. Hendil KB, Khan S, Tanaka K. Simultaneous binding of PA28 and PA700 activators to 20S proteasomes. Biochem J 1998;332:749-54.
15. Adams GM, Falke S, Goldberg AL, Slaughter CA, DeMartino GN, Gogel EP. Structural and functional effects of PA700 and modulator protein on proteasomes. J Mol Biol 1997;273:646-57.
16. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol 1997;9:788-99.
17. Goldstein G, Steed M, Hammerling U, Boyse EA, Schlesinger DH, Niall HD. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci 1975;72:11-5.
18. Mannhaupt G, Schnall R, Karpov V, Vetter I, Feldmann H. Rpn-4p acts as a transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and other genes in yeast. FEBS lett 1999;450(1-2):27-34.
19. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;276:27936-43.
20. Lam YA, DeMartino GN, Pickart CM, Cohen RE. Specificity of the ubiquitin isopeptidase in the PA700 regulatory complex of 26S proteasomes. J Biol Chem 1997;272:28438-46.
21. Wilkinson KD. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J 1997;11:1245-56.
22. Wilkinson KD, Laleli-Sahin E, Urbauer J, Larsen C, Shih GH, Haas AL, et al. The binding site for UCH-L3 on ubiquitin: mutagenesis and NMR studies on the complex between ubiquitin and UCH-L3. J Mol Biol 1999;291:1067-77.
23. Kibbe MR, Nie S, Seol D, Kovesdi I, Lizonova A, Makaroun M, et al. Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells. J Vasc Surg 2000;31:364-74.